{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T07:43:15Z","timestamp":1772696595481,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1-AI068619"],"award-info":[{"award-number":["UM1-AI068619"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1-AI068617"],"award-info":[{"award-number":["UM1-AI068617"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1-AI068613"],"award-info":[{"award-number":["UM1-AI068613"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["UM1-AI068619"],"award-info":[{"award-number":["UM1-AI068619"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["UM1-AI068617"],"award-info":[{"award-number":["UM1-AI068617"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["UM1-AI068613"],"award-info":[{"award-number":["UM1-AI068613"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>In 2021, there were 38.4 million people living with HIV (PLHIV) globally, of which 20.6 million (54%) were living in Eastern and Southern Africa. Longitudinal studies, inclusive of community randomized trials (CRTs), provide critical evidence to guide a broad range of health care interventions including HIV prevention. In this study, we have used an individual-level cohort study design to evaluate the association between sex and other baseline characteristics and participant retention in the HPTN 071 (PopART) trial in Zambia and South Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>HPTN 071 (PopART) was a community randomized trial (CRT) conducted from 2013 to 2018, in 21 communities. The primary outcome was measured in a randomly selected population cohort (PC), followed up over 3 to 4\u00a0years at annual rounds. PC retention was defined as completion of an annual follow-up questionnaire. Baseline characteristics were described by study arm and Poisson regression analyses used to measure the association between baseline factors and retention. In addition, we present a description of researcher-documented reasons for study withdrawal by PC participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 38,474 participants enrolled during the first round of the trial (PC0), most were women (27,139, 71%) and 73% completed at least one follow-up visit. Retention was lower in men (adj RR: 0.90; 95% CI: 0.88, 0.91) and higher among older participants (adj RR: 1.23; 95% CI 1.20, 1.26) when comparing ages 35\u201344 to 18\u201324\u00a0years. Retention was higher among individuals with high socioeconomic status (SES) (adj RR 1.16; 95% CI 1.14, 1.19) and medium SES (adj RR 1.12; 95% CI 1.09, 1.14) compared to low SES. The most common reasons for study withdrawal were study refusal (23%) and relocation outside the CRT catchment area (66%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite challenges, satisfactory retention outcomes were achieved in PopART with limited variability across study arms. In keeping with other studies, younger age, male sex, and lower SES were associated with lower levels of retention. Relocation outside of catchment area was the most common reason for non-retention in this CRT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07404-y","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T06:02:15Z","timestamp":1687845735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictors of participant retention in a community-based HIV prevention cohort: perspectives from the HPTN 071 (PopART) study"],"prefix":"10.1186","volume":"24","author":[{"given":"Nomtha","family":"Bell-Mandla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeksha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Sloot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Bwalya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ab","family":"Schaap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Piwowar-Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozizwe","family":"Makola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lungiswa","family":"Nkonki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musonda","family":"Simwinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayana","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Ayles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3211-6078","authenticated-orcid":false,"given":"Peter","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the HPTN 071 (PopART) Study Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"key":"7404_CR1","volume-title":"AIDSinfo datasheet","author":"UNAIDS","year":"2021","unstructured":"UNAIDS. AIDSinfo datasheet. Geneva: UNAIDS; 2021."},{"key":"7404_CR2","unstructured":"G. Joubert, Rodney Ehrlich, Judy M. Katzenellenbogen, S. S. Abdool Karim. Epidemiology : a research manual for South Africa, 2nd Edition. Oxford University Press Southern Africa, Cape Town 2007 ISBN 9780195762778, 0195762770."},{"issue":"s1","key":"7404_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-3156.2010.02508.x","volume":"15 Suppl 1","author":"MP Fox","year":"2010","unstructured":"Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007\u20132009: systematic review. Trop Med Int Health. 2010;15 Suppl 1(s1):1\u201315.","journal-title":"Trop Med Int Health"},{"issue":"2","key":"7404_CR4","doi-asserted-by":"publisher","first-page":"e0246471","DOI":"10.1371\/journal.pone.0246471","volume":"16","author":"S Kusemererwa","year":"2021","unstructured":"Kusemererwa S, Akena D, Nakanjako D, Kigozi J, Nanyunja R, Nanfuka M, et al. Strategies for retention of heterosexual men in HIV care in sub-Saharan Africa: a systematic review. PLoS ONE. 2021;16(2):e0246471.","journal-title":"PLoS One"},{"issue":"4","key":"7404_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1473-3099(13)70692-3","volume":"14","author":"B Grinsztejn","year":"2014","unstructured":"Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14(4):281\u201390.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"7404_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15284336.2018.1513711","volume":"19","author":"J Wynne","year":"2018","unstructured":"Wynne J, Muwawu R, Mubiru MC, Kamira B, Kemigisha D, Nakyanzi T, et al. Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study. HIV Clin Trials. 2018;19(5):165\u201371.","journal-title":"HIV Clin Trials"},{"key":"7404_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1745-6215-14-230","volume":"14","author":"CC Iwuji","year":"2013","unstructured":"Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials. 2013;14:230.","journal-title":"Trials"},{"issue":"3","key":"7404_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1056\/NEJMoa1809866","volume":"381","author":"DV Havlir","year":"2019","unstructured":"Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J, et al. HIV testing and treatment with the use of a community health approach in rural Africa. N Engl J Med. 2019;381(3):219\u201329.","journal-title":"N Engl J Med"},{"issue":"4","key":"7404_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1310\/hct1204-190","volume":"12","author":"S Krishnan","year":"2011","unstructured":"Krishnan S, Wu K, Smurzynski M, Bosch RJ, Benson CA, Collier AC, et al. Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis. HIV Clin Trials. 2011;12(4):190\u2013200.","journal-title":"HIV Clin Trials"},{"issue":"4","key":"7404_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/01.qai.0000148532.12329.df","volume":"39","author":"G de Bruyn","year":"2005","unstructured":"de Bruyn G, Hudgens MG, Sullivan PS, Duerr AC. Participant retention in clinical trials of candidate HIV vaccines. J Acquir Immune Defic Syndr. 2005;39(4):499\u2013501.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"7404_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1186\/s12879-019-4328-1","volume":"19","author":"Y Mayanja","year":"2019","unstructured":"Mayanja Y, Abaasa A, Namale G, Asiki G, Price MA, Kamali A. Factors associated with vaccination completion and retention among HIV negative female sex workers enrolled in a simulated vaccine efficacy trial in Kampala, Uganda. BMC Infect Dis. 2019;19(1):725.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"7404_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-021-05198-5","volume":"22","author":"V Bond","year":"2021","unstructured":"Bond V, Hoddinott G, Viljoen L, Ngwenya F, Simuyaba M, Chiti B, et al. How \u2018place\u2019 matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South Africa. Trials. 2021;22(1):1\u201313.","journal-title":"Trials"},{"issue":"3","key":"7404_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1814556","volume":"381","author":"RJ Hayes","year":"2019","unstructured":"Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, et al. Effect of universal testing and treatment on HIV incidence - HPTN 071 (PopART). N Engl J Med. 2019;381(3):207\u201318.","journal-title":"N Engl J Med"},{"issue":"1","key":"7404_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1745-6215-15-57","volume":"15","author":"R Hayes","year":"2014","unstructured":"Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial. Trials. 2014;15(1):57.","journal-title":"Trials"},{"issue":"1","key":"7404_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12874-021-01415-6","volume":"21","author":"NF Bell-Mandla","year":"2021","unstructured":"Bell-Mandla NF, Sloot R, Maarman G, Griffith S, Moore A, Floyd S, et al. Improving retention of community-recruited participants in HIV prevention research through Saturday household visits; findings from the HPTN 071 (PopART) study in South Africa. BMC Med Res Methodol. 2021;21(1):242.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"7404_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11904-016-0322-z","volume":"13","author":"M Simwinga","year":"2016","unstructured":"Simwinga M, Bond V, Makola N, Hoddinott G, Belemu S, White R, et al. Implementing community engagement for combination prevention: lessons learnt from the first year of the HPTN 071 (PopART) community-randomized study. Curr HIV\/AIDS Rep. 2016;13(4):194\u2013201.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"7404_CR17","doi-asserted-by":"publisher","first-page":"108441","DOI":"10.1016\/j.jsat.2021.108441","volume":"127","author":"DL Atkins","year":"2021","unstructured":"Atkins DL, Cumbe VFJ, Muanido A, Manaca N, Fumo H, Chiruca P, et al. Validity and item response theory properties of the Alcohol Use Disorders Identification Test for primary care alcohol use screening in Mozambique (AUDIT-MZ). J Subst Abuse Treat. 2021;127:108441.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"7404_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1812281","volume":"381","author":"J Makhema","year":"2019","unstructured":"Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, et al. Universal testing, expanded treatment, and incidence of HIV infection in Botswana. N Engl J Med. 2019;381(3):230\u201342.","journal-title":"N Engl J Med"},{"issue":"3","key":"7404_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1814556","volume":"381","author":"RJ Hayes","year":"2019","unstructured":"Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, et al. Effect of universal testing and treatment on HIV incidence\u2014HPTN 071 (PopART). N Engl J Med. 2019;381(3):207\u201318.","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"7404_CR20","first-page":"19","volume":"20","author":"P Bock","year":"2017","unstructured":"Bock P, Phiri C, Piwowar-Manning E, Kosloff B, Mandla N, Young A, et al. Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa. J Int AIDS Soc. 2017;20(Suppl 6):19\u201327.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"7404_CR21","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1007\/s10461-021-03310-z","volume":"25","author":"N Soni","year":"2021","unstructured":"Soni N, Gigu\u00e8re K, Boily MC, Fogel JM, Maheu-Giroux M, Dimitrov D, et al. Under-reporting of known HIV-positive status among people living with HIV: a systematic review and meta-analysis. AIDS Behav. 2021;25(12):3858\u201370.","journal-title":"AIDS Behav"},{"issue":"10","key":"7404_CR22","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1080\/09540120801926977","volume":"20","author":"R Smith","year":"2008","unstructured":"Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one\u2019s HIV-positive status, stigma and social support. AIDS Care. 2008;20(10):1266\u201375.","journal-title":"AIDS Care"},{"issue":"Suppl 1","key":"7404_CR23","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/QAD.0000000000000671","volume":"29 Suppl 1","author":"CE Kennedy","year":"2015","unstructured":"Kennedy CE, Fonner VA, Armstrong KA, O\u2019Reilly KR, Sweat MD. Increasing HIV serostatus disclosure in low and middle-income countries: a systematic review of intervention evaluations. Aids. 2015;29 Suppl 1(Suppl 1):S7-s23.","journal-title":"Aids"},{"issue":"1","key":"7404_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13063-021-05198-5","volume":"22","author":"V Bond","year":"2021","unstructured":"Bond V, Hoddinott G, Viljoen L, Ngwenya F, Simuyaba M, Chiti B, et al. How \u2018place\u2019 matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South Africa. Trials. 2021;22(1):251.","journal-title":"Trials"},{"issue":"1","key":"7404_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12874-018-0586-7","volume":"18","author":"S Teague","year":"2018","unstructured":"Teague S, Youssef GJ, Macdonald JA, Sciberras E, Shatte A, Fuller-Tyszkiewicz M, et al. Retention strategies in longitudinal cohort studies: a systematic review and meta-analysis. BMC Med Res Methodol. 2018;18(1):151.","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"7404_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1159\/000511889","volume":"237","author":"KN Price","year":"2021","unstructured":"Price KN, Lyons AB, Hamzavi IH, Hsiao JL, Shi VY. Facilitating clinical trials participation of low socioeconomic status patients. Dermatology. 2021;237(5):843\u20136.","journal-title":"Dermatology"},{"key":"7404_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1472-6874-14-88","volume":"14","author":"B Magazi","year":"2014","unstructured":"Magazi B, Stadler J, Delany-Moretlwe S, Montgomery E, Mathebula F, Hartmann M, et al. Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg. South Africa BMC Womens Health. 2014;14:88.","journal-title":"South Africa BMC Womens Health"},{"key":"7404_CR28","volume-title":"Framework on integrated people-centred health services","author":"World Health Organisation","year":"2016","unstructured":"World Health Organisation. Framework on integrated people-centred health services. Geneva: World Health Organisation; 2016."},{"key":"7404_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-6405-7-10","volume":"7","author":"G Ramjee","year":"2010","unstructured":"Ramjee G, Coumi N, Dladla-Qwabe N, Ganesh S, Gappoo S, Govinden R, et al. Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal South Africa. AIDS Res Ther. 2010;7:10.","journal-title":"AIDS Res Ther"},{"issue":"5","key":"7404_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cct.2009.05.002","volume":"30","author":"S Gappoo","year":"2009","unstructured":"Gappoo S, Montgomery ET, Gerdts C, Naidoo S, Chidanyika A, Nkala B, et al. Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe. Contemp Clin Trials. 2009;30(5):411\u20138.","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"7404_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1467-842X.2006.tb00849.x","volume":"30","author":"AF Young","year":"2006","unstructured":"Young AF, Powers JR, Bell SL. Attrition in longitudinal studies: who do you lose? Aust N Z J Public Health. 2006;30(4):353\u201361.","journal-title":"Aust N Z J Public Health"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07404-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07404-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07404-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T18:01:19Z","timestamp":1687888879000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07404-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7404"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07404-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1881000\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]},"assertion":[{"value":"27 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}